CARDIFF ONCOLOGY, INC. Other Comprehensive Income (Loss), Net of Tax
CARDIFF ONCOLOGY, INC. (CRDF) reported Other Comprehensive Income (Loss), Net of Tax of -$13.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$13.00K.
- CARDIFF ONCOLOGY, INC. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$99.00K.
- CARDIFF ONCOLOGY, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $33.00K, a 81.56% decline year-over-year.
- CARDIFF ONCOLOGY, INC. other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was -$10.00K, a 128.57% decline year-over-year.
- CARDIFF ONCOLOGY, INC. other comprehensive income (loss), net of tax for fiscal 2025 was $16.00K, a 84.16% decline from fiscal 2024.
- CARDIFF ONCOLOGY, INC. other comprehensive income (loss), net of tax for fiscal 2024 was $101.00K, a 69.21% decline from fiscal 2023.
- CARDIFF ONCOLOGY, INC. other comprehensive income (loss), net of tax for fiscal 2023 was $328.00K.
- CARDIFF ONCOLOGY, INC. other comprehensive income (loss), net of tax for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$13.00K 10-Q · filed 2026-08-11 | -$112.00K derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2026-03-31 | -$99.00K 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | $16.00K 10-K · filed 2026-02-24 | |||
| 2025-09-30 | $33.00K 10-Q · filed 2025-11-06 | $23.00K derived: sum of 2 quarters · filed 2026-08-11 | $16.00K derived: sum of 3 quarters · filed 2026-08-11 | |
| 2025-06-30 | -$10.00K 10-Q · filed 2026-08-11 | -$17.00K derived: sum of 2 quarters · filed 2026-08-11 | ||
| 2025-03-31 | -$7.00K 10-Q · filed 2026-08-11 | |||
| 2024-12-31 | $101.00K 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $179.00K 10-Q · filed 2025-11-06 | $214.00K derived: sum of 2 quarters · filed 2025-11-06 | $149.00K derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $35.00K 10-Q · filed 2025-11-06 | -$30.00K derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | -$65.00K 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $328.00K 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $24.00K 10-Q · filed 2024-11-07 | -$331.00K derived: sum of 2 quarters · filed 2024-11-07 | -$12.00K derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$355.00K 10-Q · filed 2024-11-07 | -$36.00K derived: sum of 2 quarters · filed 2024-11-07 | ||
| 2023-03-31 | $319.00K 10-Q · filed 2024-11-07 | |||
| 2022-09-30 | $203.00K 10-Q · filed 2023-11-02 | -$31.00K derived: sum of 2 quarters · filed 2023-11-02 | -$637.00K derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-06-30 | -$234.00K 10-Q · filed 2023-11-02 | -$840.00K derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-03-31 | -$606.00K 10-Q · filed 2023-11-02 | |||
| 2021-09-30 | $26.00K 10-Q · filed 2022-11-03 | $83.00K derived: sum of 2 quarters · filed 2022-11-03 | $16.00K derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $57.00K 10-Q · filed 2022-11-03 | -$10.00K derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | -$67.00K 10-Q · filed 2022-11-03 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $0.00 derived: sum of 2 quarters · filed 2019-03-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-06 | $0.00 10-K · filed 2019-03-06 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | $15.19K derived: sum of 4 quarters · filed 2019-03-06 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | $15.19K derived: sum of 3 quarters · filed 2019-03-06 | $13.65K derived: sum of 4 quarters · filed 2019-03-06 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-08 | $15.19K derived: sum of 2 quarters · filed 2019-03-06 | $13.65K derived: sum of 3 quarters · filed 2019-03-06 | $13.63K derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-12-31 | $15.19K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $13.65K derived: sum of 2 quarters · filed 2019-03-06 | $13.63K derived: sum of 3 quarters · filed 2019-03-06 | $10.77K 10-K · filed 2019-03-06 |
| 2017-09-30 | -$1.54K 10-Q · filed 2018-11-07 | -$1.57K derived: sum of 2 quarters · filed 2018-11-07 | -$4.42K 10-Q · filed 2018-11-07 | -$15.19K derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | -$24.00 10-Q · filed 2018-08-03 | -$2.88K 10-Q · filed 2018-08-03 | -$13.65K derived: sum of 3 quarters · filed 2018-08-03 | -$21.73K derived: sum of 4 quarters · filed 2018-08-03 |
| 2017-03-31 | -$2.85K 10-Q · filed 2018-05-08 | -$13.63K derived: sum of 2 quarters · filed 2018-05-08 | -$21.70K derived: sum of 3 quarters · filed 2018-05-08 | -$17.72K derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | -$10.77K 10-K · filed 2017-03-15 | -$18.85K derived: sum of 2 quarters · filed 2017-11-09 | -$14.86K derived: sum of 3 quarters · filed 2017-11-09 | -$10.77K 10-K · filed 2018-02-26 |
| 2016-09-30 | -$8.08K 10-Q · filed 2017-11-09 | -$4.09K derived: sum of 2 quarters · filed 2017-11-09 | -$4.74K 10-Q · filed 2017-11-09 | -$4.74K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $3.99K 10-Q · filed 2017-08-09 | $3.34K 10-Q · filed 2017-08-09 | $3.34K derived: sum of 3 quarters · filed 2017-08-09 | $3.34K derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | -$651.00 10-Q · filed 2017-05-10 | -$651.00 derived: sum of 2 quarters · filed 2017-05-10 | -$651.00 derived: sum of 3 quarters · filed 2017-05-10 | -$651.00 derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 derived: sum of 3 quarters · filed 2017-03-15 | $0.00 derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-04 | $0.00 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |